New research shows a single psilocybin session with therapy can reduce depression in cancer patients for up to two years.

A first-of-its-kind clinical trial shows that ketamine treatment for severe, treatment-resistant depression is significantly more effective when paired with psychotherapy and supportive environments.

About half of patients had sustained reduction in depression and anxiety up to two years after psilocybin and psychotherapy.

Colorado policymakers, including Gov. Jared Polis and Attorney General Phil Weiser, expressed enthusiasm about the potential ...

In a phase 2 trial, about half of cancer patients reported sustained reductions in depression and anxiety 2 years after a ...

Half a decade after receiving a psychedelic treatment for depression, two-thirds of patients in a new study remained in ...

Kate Schroeder’s journey began seven years ago when one of her therapy clients brought up the idea of using psilocybin — also known as magic mushrooms — to help treat post-traumatic stress disorder.

Psilocybin-assisted therapy offers long-term relief from depression in cancer patients, with effects lasting up to two years after one dose.

A first-of-its-kind clinical trial found that ketamine's benefits for treating severe depression can be improved when ...

Scientists have dug up more evidence of the benefits of so-called "magic" mushrooms with the publication of clinical trial ...